Majopa Industries Corporation recalls Label reads in part as: "GRAVIOLA EXTRACT***1 FL Oz (30 ml)*** ORIGINAL FORMULA***Manufactured by: Majopa Industries Co…
- Recall date
- July 31, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- F-3245-2015
- FDA classification
- Class I
- Brand / firm
- Majopa Industries Corporation
- Sold / distributed
- Puerto Rico only
Why it was recalled
Firm's dietary supplements were being promoted for conditions that caused the products to be drugs under the FD&C Act.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Label reads in part as: "GRAVIOLA EXTRACT***1 FL Oz (30 ml)*** ORIGINAL FORMULA***Manufactured by: Majopa Industries Corp.*** PRODUCT OF PUERTO RICO,USA". Drug claims in the product label are as follows: "Researchers have found that Extracts from Graviola leaves can produce acetogenins which are extremely effective in the treatment of cancer cells. Graviola extract can works like an antibiotic against cancer cells by stopping growth of the enzymes needed for cell growth. It can be:cellular protector, anti tumorous, antiviral. Also can be used as: Digestive stimulant, Strengthens immune system, antifungal, tranquilizer".
Get recall alerts
Free email alert whenever Majopa Industries Corporation has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Majopa Industries Corporation